{"id":"W4379332798","doi":"10.1200/jco.2023.41.16_suppl.4098","title":"BOLD-100-001 (TRIO039): A phase 1b/2a study of BOLD-100 in combination with FOLFOX chemotherapy in patients with pre-treated advanced gastric and biliary tract cancer: Efficacy and safety analysis.","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cholangiocarcinoma and Gallbladder Cancer Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"ca_institutions":"Translational Research in Oncology; Jewish General Hospital; Princess Margaret Cancer Centre; Ottawa Hospital; University Health Network","funders":"","keywords":"FOLFOX; Medicine; Internal medicine; Clinical endpoint; Cohort; Gastroenterology; Oncology; Cancer; Phases of clinical research; Progressive disease; Chemotherapy; Surgery; Clinical trial; Colorectal cancer; Oxaliplatin","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001574923,0.001161564,0.001287691,0.0004655997,0.0003347123,0.0007692071,0.0008151737,0.001017539,0.003028887],"category_scores_gemma":[0.0006102584,0.0004906793,0.001021652,0.0004922004,0.0006861044,0.0004573863,0.0004037414,0.002881588,0.000736178],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009760225,"about_ca_system_score_gemma":0.001809566,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001680108,"about_ca_topic_score_gemma":0.004542995,"domain_scores_codex":[0.9996698,0.0001689508,0.00001662215,0.0000435207,0.00004234636,0.00005883461],"domain_scores_gemma":[0.9994059,0.00009055679,0.0001162598,0.00004982721,0.00003592227,0.000301505],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.4401542,0.1929062,0.01762743,0.001145761,0.001813708,0.0006725644,0.0005538818,0.006707889,0.1747171,0.0004628083,0.007419148,0.1558193],"study_design_scores_gemma":[0.2763151,0.6837953,0.01847531,0.00004150502,0.0004749215,0.0006332373,0.00006491508,0.002469909,0.01299853,0.0001591616,0.004526042,0.00004614469],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9934957,0.001246533,0.000542491,0.0003880477,0.00003694056,0.001626339,0.0009984841,0.00008695339,0.00157853],"genre_scores_gemma":[0.9830621,0.00204017,0.003007216,0.0009776481,0.000084705,0.001918806,0.004911943,0.00005745108,0.003939934],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003028887,"threshold_uncertainty_score":0.01013267,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04174982015737085,"score_gpt":0.4195633865741152,"score_spread":0.3778135664167444,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}